Anand Tandon, Independent Analyst, says insurance is a long-term business which continues to accumulate capital and therefore the ability to generate money out of it. Tandon considers it to be…
" I think there is a longer-term challenge to the business. Near-term, of course, the deal gains have been fairly robust. So this year is going to be definitely a…
To think that pharma can continue to go the same way, especially after the kind of steep rally it has seen, is being overly bullish, says the independent market expert.…